CN101537121B - Chinese medicine for treating arteriosclerosis - Google Patents
Chinese medicine for treating arteriosclerosis Download PDFInfo
- Publication number
- CN101537121B CN101537121B CN2008101021902A CN200810102190A CN101537121B CN 101537121 B CN101537121 B CN 101537121B CN 2008101021902 A CN2008101021902 A CN 2008101021902A CN 200810102190 A CN200810102190 A CN 200810102190A CN 101537121 B CN101537121 B CN 101537121B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- polygonatum
- arteriosclerosis
- uncaria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
技术领域technical field
本发明属于治疗心脏病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating heart disease.
背景技术Background technique
现有的用于治疗动脉硬化的中药,存在一个突出的问题:就是治疗效果不够明显,以致于许多动脉硬化患者希望用中药长期调养治疗,而又找不到效果确切、疗效显著的中药,对此患者多有不满意。Existing Chinese medicines for treating arteriosclerosis have a prominent problem: the therapeutic effect is not obvious enough, so that many patients with arteriosclerosis hope to use Chinese medicines for long-term care and treatment, but they cannot find a Chinese medicine with definite effect and significant curative effect. This patient is dissatisfied.
针对以上提出的问题,本发明提供一种治疗动脉硬化的中药,它能解决以往此类中药效果不够明显的问题,具有效果较好、疗效确切的优点。Aiming at the problems raised above, the present invention provides a traditional Chinese medicine for treating arteriosclerosis, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and has the advantages of good effect and definite curative effect.
发明内容Contents of the invention
本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:
一种治疗动脉硬化的中药,采用中药原料制备,配方为(按重量比):A kind of Chinese medicine for treating arteriosclerosis, adopts Chinese medicine raw material to prepare, and formula is (by weight):
女贞子0.3-2.6份 白芍0.4-3.2份 当归0.3-2.6份Ligustrum lucidum 0.3-2.6 parts White peony 0.4-3.2 parts Angelica 0.3-2.6 parts
旱莲草0.3-2.6份 钩藤0.3-2.6份 灵芝0.15-1份Eclipta 0.3-2.6 parts Uncaria 0.3-2.6 parts Ganoderma lucidum 0.15-1 parts
玉竹0.3-2.6份 三七0.3-2.6份Polygonatum 0.3-2.6 parts Panax notoginseng 0.3-2.6 parts
这种治疗动脉硬化的中药是由下列方法制成的:This traditional Chinese medicine for arteriosclerosis is made by the following methods:
(1)按上述重量比,将女贞子、白芍、当归、旱莲草、钧藤、玉竹经常规水提取工艺提取,制成浸膏细粉;(1) According to the above-mentioned weight ratio, Ligustrum lucidum, Radix Paeoniae Alba, Angelica sinensis, Eclipta chinensis, Junteng, Polygonatum odoratum are extracted through a conventional water extraction process to make extract powder;
(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
本发明是根据民间传统配方,根据中医活血化瘀的理论,精心研制而成。中医认为,动脉硬化症见长期心慌、心悸、气紧,稍事活动心律即增至120次/分钟左右,头晕眼花,睡眠欠佳,四肢发麻,心肌缺血,属阴虚阳亢,湿热痹阻,治当滋阴潜阳,养血通脉,活血化瘀。本方灵芝益气,扶正培本,大补元气;女贞子、旱莲草、玉竹滋养心肝肾三脏之阴,白芍、钩藤平肝潜阳;三七、当归活血化瘀,行通血脉。诸药配伍,相得益彰,共奏扶正培本,养血通脉,活血化瘀之功,效果好,见效快,具有效果较好,疗效确切的优点。The present invention is elaborately developed according to folk traditional formula and the theory of promoting blood circulation and removing blood stasis in traditional Chinese medicine. Traditional Chinese medicine believes that arteriosclerosis is characterized by long-term palpitation, heart palpitations, shortness of breath, a slight increase in heart rate to about 120 beats per minute, dizziness, poor sleep, numbness in the limbs, myocardial ischemia, and it belongs to yin deficiency and yang hyperactivity, damp heat For numbness resistance, control when nourishing yin and suppressing yang, nourishing blood and promoting blood circulation to remove blood stasis. Ganoderma lucidum invigorates qi, strengthens the body and nourishes vitality; Ligustrum lucidum, eclipta, Polygonatum nourishes the yin of the heart, liver and kidney, white peony root and Uncaria calm the liver and suppresses yang; Panax notoginseng, angelica promotes blood circulation and removes blood stasis, Pass the blood. All the medicines are compatible and complement each other, and they play the functions of strengthening the body, nourishing the blood and dredging the veins, promoting blood circulation and removing blood stasis.
具体实施方式Detailed ways
通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:
1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):
女贞子55克 白芍65克 当归55克Ligustrum lucidum 55 grams White peony 65 grams Angelica 55 grams
旱莲草55克 钩藤40克 灵芝25克Eclipta 55g Uncaria 40g Ganoderma lucidum 25g
玉竹45克 三七45克Polygonatum Polygonatum 45g Panax notoginseng 45g
按规定重量,用常规水提取工艺将女贞子、白芍、当归、旱莲草、钧藤、玉竹提取,制成浸膏细粉110克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊642粒,每粒胶囊内含中药细粉及提取物0.28克。Extract Ligustrum lucidum, Radix Paeoniae Alba, Angelica, Eclipta, Junteng, and Polygonatum odoratum by conventional water extraction process to make 110 grams of extract powder, and grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, according to the specified weight. Mix with above-mentioned extractum fine powder, stir evenly, make fine particle, pack into No. 0 capsule, make 642 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and extract 0.28 gram.
2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):
女贞子130克 白芍200克 当归160克Ligustrum lucidum 130g White peony 200g Angelica 160g
旱莲草160克 钩藤120克 灵芝70克Eclipta 160g Uncaria 120g Ganoderma lucidum 70g
玉竹160克 三七150克Polygonatum 160g Panax notoginseng 150g
按上述同样的方法,制成中药胶囊1948粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1948 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):
女贞子260克 白芍320克 当归260克Ligustrum lucidum 260 grams White peony root 320 grams Angelica 260 grams
旱莲草260克 钩藤260克 灵芝100克Eclipta 260g Uncaria 260g Ganoderma lucidum 100g
玉竹260克 三七260克Polygonatum Polygonatum 260g Panax notoginseng 260g
按上述同样的方法,制成中药胶囊3310粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 3310 Chinese medicine capsules were made, and each capsule contained Chinese medicine fine powder and 0.28 grams of extract.
4、取以下配方(按重量比):4. Take the following formula (by weight):
女贞子5份 白芍6.5份 当归5.5份Ligustrum lucidum 5 parts White peony root 6.5 parts Angelica sinensis 5.5 parts
旱莲草5.2份 钩藤5.5份 灵芝3.5份Eclipta 5.2 parts Uncaria 5.5 parts Ganoderma lucidum 3.5 parts
玉竹5.6份 三七5.6份Polygonatum 5.6 parts Panax notoginseng 5.6 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
5、取以下配方(按重量比):5. Take the following formula (by weight):
女贞子25份 白芍28份 当归26份Ligustrum lucidum 25 parts White peony 28 parts Angelica 26 parts
旱莲草24份 钩藤24份 灵芝9份Eclipta 24 parts Uncaria 24 parts Ganoderma lucidum 9 parts
玉竹25份 三七25份Polygonatum 25 parts Panax notoginseng 25 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
临床资料:clinical information:
本发明以中医动脉硬化为例,经24例临床观察。选择中医诊断动脉硬化为标准:体质虚弱,体乏无力,心慌、心悸、气紧,稍事活动,心律即增至120次/分钟左右,头晕眼花,睡眠欠佳,四肢发麻,心肌缺血。如上症状,即可确诊。在确诊观察的对象中,男性14例,女性10例,无其它严重疾病,年龄为37岁-77岁,平均年龄54.6岁。The present invention takes TCM arteriosclerosis as an example, through 24 clinical observations. Choose TCM diagnosis of arteriosclerosis as the standard: weak constitution, physical weakness, palpitation, palpitation, shortness of breath, slight activity, heart rate increases to about 120 beats/min, dizziness, poor sleep, numbness of limbs, myocardial ischemia . The above symptoms can be diagnosed. Among the confirmed observation objects, there were 14 males and 10 females, without other serious diseases, aged from 37 to 77 years old, with an average age of 54.6 years.
疗效判定:Judgment of curative effect:
1、显效:体质增强,身上有劲,心慌、心悸、气紧,心动过速,肢体麻木,心肌缺血,睡眠欠佳等症状明显缓解。1. Significant effect: Physical fitness is enhanced, body is strong, palpitation, heart palpitations, shortness of breath, tachycardia, numbness of limbs, myocardial ischemia, poor sleep and other symptoms are significantly relieved.
2、有效:体质增强,心慌、心悸、气紧,麻木等症状有所缓解。2. Effective: Physical fitness is enhanced, and symptoms such as palpitation, heart palpitations, tightness of breath, and numbness are relieved.
3、无效:病症无变化。3. Ineffective: no change in symptoms.
临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。临床实验的24人中,显效11人,有效10人,无效3人,总有效率87.5%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 3 months of taking, Symptoms improved significantly. Among the 24 people in the clinical trial, 11 were markedly effective, 10 were effective, and 3 were ineffective, with a total effective rate of 87.5%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101021902A CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101021902A CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101537121A CN101537121A (en) | 2009-09-23 |
| CN101537121B true CN101537121B (en) | 2011-04-27 |
Family
ID=41120662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101021902A Expired - Fee Related CN101537121B (en) | 2008-03-19 | 2008-03-19 | Chinese medicine for treating arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101537121B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101850015B (en) * | 2009-09-25 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating arteriosclerosis |
| CN103239583B (en) * | 2013-05-13 | 2015-06-17 | 周柳池 | Airuike heart-soothing granule |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413601A (en) * | 2001-10-22 | 2003-04-30 | 孟宪茹 | Chinese medicine for compound circulation treatment of angiocardiopathy and cerebrovascular disease |
| CN1586544A (en) * | 2004-07-14 | 2005-03-02 | 张国强 | Medicinal wine and its producing method |
-
2008
- 2008-03-19 CN CN2008101021902A patent/CN101537121B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413601A (en) * | 2001-10-22 | 2003-04-30 | 孟宪茹 | Chinese medicine for compound circulation treatment of angiocardiopathy and cerebrovascular disease |
| CN1586544A (en) * | 2004-07-14 | 2005-03-02 | 张国强 | Medicinal wine and its producing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101537121A (en) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843661A (en) | Chinese medicament for treating angina | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN101537114B (en) | Chinese medicine for treating arrhythmia | |
| CN101537121A (en) | Chinese medicine for treating arteriosclerosis | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101396468B (en) | A kind of traditional Chinese medicine for treating diabetic coronary heart disease | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101554412B (en) | Traditional Chinese medicine for treating atrial fibrillation | |
| CN101396454B (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843796A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843726A (en) | Chinese medicament for treating chronic hepatitis | |
| CN101991743A (en) | Traditional Chinese medicine for treating diabetic heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO GRINDING HEAD CONSTRUCTION DEVELOPMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: 226500 Guangming West Road, grinding head town, Rugao, Jiangsu Patentee after: Rugao grinding head Construction Development Co Ltd Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602 Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20190319 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |